Name | No. | For Patients with | Purpose |
---|---|---|---|
PUMA-NER 5201/SUMMIT | CTRIAL-IE 19-22 |
DSSG Group: Basket (multiple types)
MK7339-002 / LYNK-002
Name | No. | For Patients with | Purpose |
---|---|---|---|
MK7339-002 / LYNK-002 | CTRIAL-IE 19-27 | Multiple types of cancer |
This study will evaluate the efficacy and safety of olaparib monotherapy in participants with multiple types of advanced cancer (unresectable and/or metastatic). |
Add-Asprin
Name | No. | For Patients with | Purpose |
---|---|---|---|
Add-Asprin | 16-19 | Non-metastatic breast, colorectal, gastro-oesophagal or prostate cancer which can be treated and potentially cured. |
The purpose of this study is to evaluate the the effects of aspirin on disease recurrence and survival in patients who have had primary curative therapy for common non-metastatic solid tumours. |